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a b s t r a c t
Chondrosarcoma of a rib is a very rare malignant tumor of the bone. Most patients were present with
an enlarging painful anterior chest wall tumor. We present a case of an asymptomatic 29-years old
female with a tumor size of 10 cm×12 cm on the left anterior chest wall involving the 8th rib. CT scan
with intravenous contrast is the gold standard for radiological imaging and planning for surgery. Since
chondrosarcoma is less sensitive to chemotherapy and radiotherapy, surgical treatment with extensive
resection with a sufﬁcient margin is considered ﬁrst line treatment.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Chondrosarcoma is a malignant tumor exhibiting neoplastic
chondrogenesis. It often arises in the pelvis or long bones, and is
relatively rare for chondrosarcoma to arise in the rib [1–2]. CT with
intravenous contrast is the gold standard radiographic study for
diagnosis and operative planning [3–4]. Since they do not respond
well to chemotherapy or radiotherapy, surgical treatment with
early diagnosis and radical excision with widely negative micro-
scopic margins at the initial operation is the treatment of choice
[2]. Ten years survival rate after wide resection is 96.4% compared
to 65.4% for those who had local excision only [1]. The decision
of whether to perform reconstruction is based on lesion location
and defect size. Chest wall reconstruction is recommended when
at least 3 ribs are resectedor the sizeof the chestwall defect is >3 cm
[5]. A case of an asymptomatic 29-years old female with a tumor
size of 10 cm×12 cm on the left anterior chest wall involving the
8th rib is presented through this paper which was later diagnosed
histologically as chondrosarcoma with atypical chondroblastoma
like areas.
2. Case report
A29-yearsold femalepresentedwitha swellingon the left lower
anterior chest wall for the past 5 years. Initially the swelling was
small in size which gradually progressed to reach the present size
of around 10 cm×12 cm. She was asymptomatic.
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CT-scan ﬁndings show well deﬁned lobulated round heteroge-
nous soft tissue density with hypodense areas (Fig. 2A). Necrosis
and peripheral calciﬁcations measuring 8.3 cm×7.4 cm×7 cm
noted in the anterior aspect of the 8th rib. CT scan suggested neo-
plastic etiology and chondrosarcoma is to be considered.
2.1. Surgical resections and reconstructions
Surgery was initiated for wide excision and intra-operatively, it
was found to be arising from the 8th rib and pushing the diaphragm
without invading it. The whole tumor was excised en masse along
with 7th, 8th and 9th ribs and a large portion of a diaphragm.
Diaphragm was closed with 2–0 interrupted silk sutures and
15 cm×15 cmprolenemesh placed (as shown in Fig. 1A–C descrip-
tive pictures). Intercostal drain inserted. Patient had an uneventful
recovery and being followed up for the last one-year. CT-scan two
times post-resection scan is done and there is no recurrence of
tumor.
2.2. Histopathology report of excised swelling
Gross: Mass with attached bone on one margin and covered by
muscle on one surface. The mass measures 9 cm×8 cm×7 cm.
Microscopy: Tumor is cellular in areas with tumor cells produc-
ing blue grey chondroid matrix (as shown in Fig. 1B). Binucleate
chondrocytes are seen alongwith cellswith abundant eosinophillic
cytoplasm, showing pleomorphism and atypia as well as cells
with clear cytoplasm. Mitosis is 2/10 hpf. Foci of calciﬁcations
(chicken wire pattern) and eosinophillic cartilaginous matrix are
also present. Bony trabaculae are seen. An area of secondary
aneurysmal bone cyst with cystic areas and haemorrhage seen.
Numerousmultinucleatedgiant cells are alsopresent admixedwith
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Fig. 1. (A): Intraoperative ﬁnding of tumor; (B): reconstruction with 15×15cm mesh; (C): cut section of tumor.
Fig. 2. (A): CT Scan of tumor; (B): HP showing clear cell chondrosarcoma.
tumor cells. Areas of necrosis are seen. The margins are free of
tumor cells. Features are those of clear cell chondrosarcoma with
atypical chondroblastoma like areas.
3. Discussions
Chondrosarcoma of the rib is a very raremalignant tumor. Most
of the patients presentwith an enlarging painful anterior chestwall
tumor. But this patient was asymptomatic. Chondrosarcoma usu-
ally presents above the 50-years of age and male are predominant
[6] but in the present study the patient was a 29-years old female.
CT scan is the imaging of choice and resection is performed based
on imaging characteristics. Incisional biopsy is rarely required con-
trary to previous dictum where biopsy is required prior to surgery.
With respect to treatment, chondrosarcoma is not responsive to
chemotherapyandradiotherapyandextensive resectionwitha suf-
ﬁcientmargin is considered ﬁrst line therapy.Mayo group reported
in 1985 where 10-years survival rate was 96.4% for those who had
wide resection, compared with 65.4% for those who had local exci-
sion only [2]. In 1992, the group ofmemorial Soan Kettering cancer
centre reported on their 40-years’ experience on primary bony and
cartilaginous chest wall malignancies, concluded that the single
most important factor predicting survivalwas completeness of ﬁrst
resection [7].
In the recent past, substantial new insights have been
gained about molecular cell biology, molecular cytogenetics,
and immunopathology, leading to a better understanding of
chondrosarcoma development at the molecular level, which will
ultimately lead to better clinical understanding and possibly to the
development of targeted treatment [8].
4. Conclusion
Although surgery is effective for chondrosarcoma, it is neces-
sary to prepare a safe surgical ﬁeld and perform reconstruction
by considering the onset location and resection rate. Due to the
possibility of late local and systemic recurrence, resected patients
should undergo routine lifelong surveillance. Surveillance con-
sists of physical examination and thoracic imaging with either
PA/Lateral radiograph or CT scan every 3–6 months for the ﬁrst
5-years and annually thereafter for a minimum of 10-years.
Conﬂict of interest
No conﬂict of interest.
Funding
This study does not have involvement of sponsors. It is self
funding.
Consent
Ethics committee approval taken andwritten informed consent
wasobtained fromthepatient forpublicationof this case report and
CASE REPORT – OPEN ACCESS
128 M.M.B. Sangma, S. Dasiah / International Journal of Surgery Case Reports 10 (2015) 126–128
accompanying images. A copy of thewritten consent is available for
review by Editor-in-Chief of this journal on request.
Author contribution
(1) Dr. Mima Maychet B. Sangma – study design, data collections,
data analysis, writing, computer typing.
(2) Dr. Simon Dasiah – data analysis, proof reading and review of
literature.
References
[1] R.M. King, P.C. Pairolero, V.F. Trastek, J.M. Piehler, W.S. Payne, et al., Primary
chest wall tumors: factors affecting survival, Ann. Thorac. Surg. 41 (1986)
597–601.
[2] S. Sabanathan, R. Shah, A.J. Mearns, Surgical treatment of primary malignant
chest wall tumors, Eur. J. Cardiothorac. Surg. 11 (1997) 1011–1016.
[3] P.O. Sullivan, H.O. Dwyer, J. Flint, P.L. Munk, N.L. Muller, Malignant chest wall
neoplasms of bone and cartilage: a pictorial review of CT and MR ﬁndings, Br. J.
Radiol. 80 (956) (2007) 678–684.
[4] M.K. McAfee, P.C. Pairolero, E.J. Bergstralh, J.M. Piehler, K.K. Unni, et al.,
Chondrosarcoma of the chest wall: factors affecting survival, Ann. Thorac. Surg.
40 (1985) 535–541.
[5] M.J. Weyant, M.S. Bains, E. Venkatraman, R.J. Downey, B.J. Park, et al., Results of
chest wall resection and reconstruction with and without rigid prosthesis, Ann.
Thorac. Surg. 81 (2006) 279–285.
[6] U. Tateishi, G.W. Gladish, M. Kusumoto, T. Hasegawa, R. Yokoyama, R. Tsuchiya,
et al., Chest wall tumors: radiologic ﬁndings and pathologic correlation: part 2.
Malignant tumors, Radiographics 23 (2003) 1491–1508.
[7] M. Burt, M. Futton, S. Wessner-Dunlap, et al., Primary bony and cartilaginous
sarcomas of chest wall: results of therapy, Ann.Thoracic. Surg. 54 (2) (1992)
226–232.
[8] J.V.M.G. Bovee, A.M. Cleton-Jansen, A.H.M. Taminiau, P.C.W. Hogendorn,
Emerging pathways in the development of chondrosarcoma of bone and
implications for targeted treatment, Lancet Oncol. 6 (2005) 599–607.
Open Access
This article is published Open Access at sciencedirect.com. It is distributed under the IJSCR Supplemental terms and conditions, which
permits unrestricted non commercial use, distribution, and reproduction in any medium, provided the original authors and source are
credited.
